journalEvidence level BIndependent
Evidence pageA Scoping Review of Hyaluronidase Use in Managing the Complications of Aesthetic Interventions
Aesthetic Plastic Surgery (via PubMed Central)
Published Dec 19, 2022accessed Nov 12, 2026Updated Nov 12, 2026
Original source
https://pmc.ncbi.nlm.nih.gov/articles/PMC10999391/
pmc.ncbi.nlm.nih.gov
Verification
| Verification | Independent of the subject |
| Evidence level | B · Peer-reviewed or professional body |
| Independent | Independent of the subject |
| Source | journal |
| Link status | Reachable at last check |
Official claims are statements by the provider; they are not verified by worldwiki unless marked otherwise. Source policy
Cited by (2)
FactDermal Filler: Reversal agent (HA fillers only) = Hyaluronidase, used off-label to break down HA nodules, excess filler and vascular complicationsFactDermal Filler: Evidence for hyaluronidase in vascular occlusion = No RCTs or clinical trials; evidence is limited to retrospective case series (the review itself is rated Level III)